These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17284708)

  • 1. An affair of the heart.
    Boice JD
    J Natl Cancer Inst; 2007 Feb; 99(3):186-7. PubMed ID: 17284708
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
    Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister A; Radford JA; Rohatiner AZ; Linch DC
    J Natl Cancer Inst; 2007 Feb; 99(3):206-14. PubMed ID: 17284715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
    Danilenko AA; Shakhtarina SV
    Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Late effects from radiation therapy: the hits just keep on coming.
    Aleman BM; de Bruin ML; Dorresteijn LD; Krol AD; van 't Veer MB; Boogerd W; van Leeuwen FE
    J Natl Cancer Inst; 2010 Apr; 102(8):576-7; author reply 577-8. PubMed ID: 20308649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of radiotherapy-induced heart disease on the survival of breast cancer patients].
    Gábor G
    Magy Onkol; 2005; 49(3):201-2. PubMed ID: 16320454
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
    Lister TA
    J Clin Oncol; 2008 Nov; 26(32):5144-6. PubMed ID: 18854554
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin I and cardiovascular risk stratification in patients with testicular cancer.
    Cardinale D; Lamantia G; Cipolla CM
    J Clin Oncol; 2006 Jul; 24(21):3508; author reply 3508-9. PubMed ID: 16849772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texas case raises questions about Hodgkin lymphoma treatment in children.
    Vanchieri C
    J Natl Cancer Inst; 2006 Jan; 98(1):6-8. PubMed ID: 16391363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term toxicity of curative lymphoma therapy].
    Gassmann W; Slanina J
    Internist (Berl); 1993 Feb; 34(2):161-9. PubMed ID: 8454430
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
    Yahalom J
    J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
    Longo DL
    J Natl Cancer Inst; 2005 Oct; 97(19):1394-5. PubMed ID: 16204683
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
    Hodgson DC; Hudson MM; Constine LS
    Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myocardial infarction with normal coronary arteries in a patient with Hodgkin's disease.
    Haywood LJ
    Tex Heart Inst J; 2007; 34(1):135. PubMed ID: 17420816
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatal coronary heart disease in a young woman 20 years after radiotherapy for Hodgkin disease].
    Skulstad H; Backström J
    Tidsskr Nor Laegeforen; 1999 Apr; 119(10):1431-2. PubMed ID: 10354750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.
    Cosset JM; Henry-Amar M; Meerwaldt JH
    Ann Oncol; 1991 Feb; 2 Suppl 2():77-82. PubMed ID: 2049323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.